Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07085247 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Active, Not Recruiting to Recruiting
    • Start date: May 1, 2025 to Jun 1, 2025
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to clarify the role of the bacterium Cutibacterium acnes in the development of degenerative disc disease in patients with lumbar disc herniation who underwent microdiscectomy as part of their regular medical care.
Trial Details
NCT Number NCT07085247
Lead Sponsor Masaryk University
Collaborators: St. Anne's University Hospital Brno, Czech Republic
Conditions
(from sponsor)		 Lumbar Disc Herniation, Lumbar Disc Degeneration, Cutibacterium Acnes, Low Back Pain
Related terms Intervertebral Disc Degeneration, Intervertebral Disc Displacement, Low Back Pain
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov